BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37744402)

  • 1. CDKs Functional Analysis in Low Proliferating Early-Stage Pancreatic Ductal Adenocarcinoma.
    Zhu S; Yang H; Liu L; Jiang Z; Ji J; Wang X; Zhong L; Liu F; Gao X; Wang H; Zhou Y
    J Bioinform Syst Biol; 2023; 6(3):187-200. PubMed ID: 37744402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma.
    Piao J; Zhu L; Sun J; Li N; Dong B; Yang Y; Chen L
    Gene; 2019 Jun; 701():15-22. PubMed ID: 30898709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).
    Wijnen R; Pecoraro C; Carbone D; Fiuji H; Avan A; Peters GJ; Giovannetti E; Diana P
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase.
    Yamakawa K; Koyanagi-Aoi M; Machinaga A; Kakiuchi N; Hirano T; Kodama Y; Aoi T
    Cancer Cell Int; 2023 May; 23(1):94. PubMed ID: 37198667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
    Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modification of CDK1-STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties.
    Xu X; Ding Y; Jin J; Xu C; Hu W; Wu S; Ding G; Cheng R; Cao L; Jia S
    Cell Biosci; 2023 Sep; 13(1):176. PubMed ID: 37743465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D
    Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
    Liao X; Han C; Wang X; Huang K; Yu T; Yang C; Huang R; Liu Z; Han Q; Peng T
    Cancer Manag Res; 2018; 10():3255-3271. PubMed ID: 30233242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Wang W; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Oncol; 2021; 11():643465. PubMed ID: 33912458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.
    Dong S; Huang F; Zhang H; Chen Q
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30765611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
    Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
    Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
    Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
    Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Weng S; Wang H; Chen W; Katz MH; Chatterjee D; Lee JE; Pisters PW; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1336-43. PubMed ID: 22665577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.